BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2024 9:30:52 AM | Browse: 358 | Download: 1098
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 99376
Country China
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Basic Study
Article Title BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation
Manuscript Source Unsolicited Manuscript
All Author List Qin Wang, Qing-Rong Li, Lei Xu, Zi-Chun Yuan, Xiao Liu, Mao-Ju Tang, Man Luo, Xiao-Wu Zhong, Qiang Ma and Xiao-Lan Guo
ORCID
Author(s) ORCID Number
Qin Wang http://orcid.org/0009-0003-3446-4241
Lei Xu http://orcid.org/0009-0000-9783-1385
Zi-Chun Yuan http://orcid.org/0000-0002-5522-6977
Xiao-Wu Zhong http://orcid.org/0000-0002-6643-4624
Qiang Ma http://orcid.org/0000-0002-5326-5809
Xiao-Lan Guo http://orcid.org/0000-0003-4591-0676
Funding Agency and Grant Number
Funding Agency Grant Number
Scientific Research Development Plan Project or the Scientific Research Foundation for Advanced Talents, Affiliated Hospital of North Sichuan Medical College No. 2023MPZK017, 2023ZD001, 2023-2ZD002, 2023GC009
Science and Technology Support Program of Nanchong No. 22SXQT0001
Youth Medical Innovation Research Project, or Medical Research Project of Sichuan Province No. Q23047 and No. S23020
Development of a Scientific Research Plan for the Doctoral Scientific Research Foundation of the North Sichuan Medical College No. CBY22-ZDA03
Corresponding Author Xiao-Lan Guo, MD, PhD, Professor, Department of Clinical Laboratory, Affiliated Hospital of North Sichuan Medical College, No. 1 South Maoyuan Road, Shunqing District, Nanchong 637000, Sichuan Province, China. alan5200@hotmail.com
Key Words Esophageal squamous cell carcinoma; BIBR1532; Human telomerase reverse transcriptase; DNA damage response; Telomere-binding proteins
Core Tip BIBR1532 inhibited proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) cells in a dose-dependent manner, which also effectively blocked the growth of ESCC in tumor-bearing nude mouse model. Mechanistically, BIBR1532 downregulated the expression of telomere-binding proteins, upregulated the expression of phosphorylated histone H2AX, ataxia telangiectasia and Rad3-related protein/check point kinase 1 (CHK-1) and ataxia-telangiectasia mutated gene/CHK2 pathways. The in vitro and in vivo studies showed that BIBR1532 is a potential chemotherapeutic drug for ESCC.
Publish Date 2024-12-12 09:30
Citation

Wang Q, Li QR, Xu L, Yuan ZC, Liu X, Tang MJ, Luo M, Zhong XW, Ma Q, Guo XL. BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. World J Gastrointest Oncol 2025; 17(1): 99376

URL https://www.wjgnet.com/1948-5204/full/v17/i1/99376.htm
DOI https://dx.doi.org/10.4251/wjgo.v17.i1.99376
Full Article (PDF) WJGO-17-99376-with-cover.pdf